BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
Trump administration impacts
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
Bioworld 2025 review
BioWorld MedTech 2025 review
BioWorld Science 2025 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Saturday, January 17, 2026
Home
»
Newsletters
» BioWorld Science
BioWorld Science
May 17, 2022
View Archived Issues
Hyaluronidase-expressing oncolytic virus VCN-11 shows promise as cancer immunotherapeutic
Read More
STK-002 confers a dose-dependent increase in OPA1 expression in ADOA retina
Read More
Lhotse Bio discovers lysophosphatidic acid receptor 1 antagonists
Read More
New STING agonists identified at Tyligand Bioscience
Read More
New RET inhibitors synthesized at Shanghai LiteDD
Read More
Suzhou Zelgen Biosciences patents G12C mutant GTPase KRAS inhibitors
Read More
New non-receptor tyrosine-protein kinase TYK2 inhibitors described by PharmaBlock Sciences
Read More
Multiple aging hallmarks show up as epigenetic changes
Read More
Novel zebrafish model of Opa1-mutated dominant optic atrophy
Read More
Intrathalamic administration of AVB.PGRN rescues pathology in Grn-null FTD mice
Read More
AstraZeneca selects IPF target under drug discovery collaboration with BenevolentAI
Read More
EDIT-202 iPSC-derived NK cell therapy shows tumor killing in vivo
Read More
Osivax collaborates with NIAID to combine OVX-836 with NIAID influenza vaccine candidates
Read More
Sosei Heptares and Kallyope collaborate to identify gastrointestinal GPCR targets
Sosei and Kallyope have entered a strategic research collaboration to identify and validate novel G protein-coupled receptor (GPCR) targets with a goal of creating new drug discovery programs in the area of gastrointestinal diseases.
Read More
Nanocapsules efficiently deliver single CRISPR-Cas9 across the blood-brain barrier
Read More
